ABIOMED Inc.

281.71-12.06-4.11%Vol 209.35K1Y Perf -15.25%
Aug 9th, 2022 16:00 DELAYED
BID244.45 ASK330.00
Open292.78 Previous Close293.77
Pre-Market- After-Market281.71
 - -  - -%
Target Price
347.00 
Analyst Rating
Moderate Buy 1.78
Potential %
23.18 
Finscreener Ranking
★+     42.84
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     47.37
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     61.72
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
38.80 
Earnings Rating
Strong Buy
Market Cap12.81B 
Earnings Date
4th Aug 2022
Alpha0.01 Standard Deviation0.13
Beta1.32 

Today's Price Range

281.52292.78

52W Range

219.85379.30

5 Year PE Ratio Range

21.20260.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-6.55%
1 Month
5.51%
3 Months
18.55%
6 Months
-8.27%
1 Year
-15.25%
3 Years
47.49%
5 Years
87.79%
10 Years
1 213.33%

TickerPriceChg.Chg.%
ABMD281.71-12.0600-4.11
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
81.80
24.90
27.60
30.00
20.26
RevenueValueIndustryS&P 500US Markets
779.17M
17.08
0.19
16.54
Earnings HistoryEstimateReportedSurprise %
Q01 20231.081.2515.74
Q04 20221.081.167.41
Q03 20220.981.1315.31
Q02 20220.981.035.10
Q01 20221.061.103.77
Q04 20211.101.2412.73
Q03 20211.151.171.74
Q02 20210.871.0116.09
Earnings Per EndEstimateRevision %Trend
6/2022 QR1.072.88Positive
9/2022 QR1.09-0.91Negative
3/2023 FY4.630.65Positive
3/2024 FY5.69-1.73Negative
Next Report Date-
Estimated EPS Next Report1.09
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume209.35K
Shares Outstanding45.46K
Shares Float35.42M
Trades Count8.08K
Dollar Volume60.68M
Avg. Volume274.97K
Avg. Weekly Volume280.11K
Avg. Monthly Volume248.92K
Avg. Quarterly Volume295.87K

ABIOMED Inc. (NASDAQ: ABMD) stock closed at 281.71 per share at the end of the most recent trading day (a -4.11% change compared to the prior day closing price) with a volume of 209.35K shares and market capitalization of 12.81B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1725 people. ABIOMED Inc. CEO is Michael R. Minogue.

The one-year performance of ABIOMED Inc. stock is -15.25%, while year-to-date (YTD) performance is -21.57%. ABMD stock has a five-year performance of 87.79%. Its 52-week range is between 219.845 and 379.295, which gives ABMD stock a 52-week price range ratio of 38.80%

ABIOMED Inc. currently has a PE ratio of 90.30, a price-to-book (PB) ratio of 8.14, a price-to-sale (PS) ratio of 15.40, a price to cashflow ratio of 43.10, a PEG ratio of 2.32, a ROA of 8.85%, a ROC of 7.12% and a ROE of 9.90%. The company’s profit margin is 20.26%, its EBITDA margin is 27.60%, and its revenue ttm is $779.17 Million , which makes it $17.08 revenue per share.

Of the last four earnings reports from ABIOMED Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.09 for the next earnings report. ABIOMED Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ABIOMED Inc. is Moderate Buy (1.78), with a target price of $347, which is +23.18% compared to the current price. The earnings rating for ABIOMED Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ABIOMED Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ABIOMED Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.68, ATR14 : 9.74, CCI20 : 81.49, Chaikin Money Flow : 0.35, MACD : 9.47, Money Flow Index : 68.69, ROC : 3.15, RSI : 56.38, STOCH (14,3) : 72.63, STOCH RSI : 0.46, UO : 64.84, Williams %R : -27.37), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ABIOMED Inc. in the last 12-months were: David M. Weber (Option Excercise at a value of $233 279), David M. Weber (Sold 25 825 shares of value $8 288 310 ), Martin P. Sutter (Sold 40 642 shares of value $13 231 148 ), Michael R. Minogue (Option Excercise at a value of $80 840), Michael R. Minogue (Sold 3 492 shares of value $1 222 200 ), Paul G. Thomas (Sold 663 shares of value $219 301 ), Todd A. Trapp (Sold 3 000 shares of value $992 430 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (66.67 %)
4 (66.67 %)
4 (57.14 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
2 (28.57 %)
Moderate Sell
1 (16.67 %)
1 (16.67 %)
1 (14.29 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.78
Moderate Buy
1.78
Moderate Buy
1.96

ABIOMED Inc.

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

CEO: Michael R. Minogue

Telephone: +1 978 646-1400

Address: 22 Cherry Hill Drive, Danvers 01923, MA, US

Number of employees: 1 725

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

62%38%

Bearish Bullish

60%40%

TipRanks News for ABMD

Sat, 30 Apr 2022 07:26 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Humana (HUM), Abiomed (ABMD) and Icon (ICLR)

- TipRanks. All rights reserved.

Thu, 31 Mar 2022 06:55 GMT Abiomed (ABMD) Gets a Hold Rating from Leerink Partners

- TipRanks. All rights reserved.

Tue, 29 Mar 2022 23:45 GMT Abiomed (ABMD) Gets a Hold Rating from BTIG

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 13:35 GMT Analysts Conflicted on These Healthcare Names: Abiomed (ABMD), Arrowhead Pharmaceuticals (ARWR) and Biogen (BIIB)

- TipRanks. All rights reserved.

News

Stocktwits